{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,9,2]],"date-time":"2023-09-02T09:42:15Z","timestamp":1693647735153},"reference-count":0,"publisher":"Frontline Medical Communications, Inc.","issue":"Suppl 3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023,8]]},"DOI":"10.12788\/fp.0401","type":"journal-article","created":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T14:54:06Z","timestamp":1693580046000},"source":"Crossref","is-referenced-by-count":0,"title":["Retrospective Evaluation of Drug-Drug Interactions With Erlotinib and Gefitinib Use in the Military Health System"],"prefix":"10.12788","volume":"40","author":[{"given":"Thu-Lan T","family":"Luonga","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"5043","container-title":["Federal Practitioner"],"original-title":[],"link":[{"URL":"https:\/\/cdn.mdedge.com\/files\/s3fs-public\/issues\/articles\/0823fdp_avaho_024.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T14:54:06Z","timestamp":1693580046000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdedge.com\/fedprac\/article\/264720\/mixed-topics\/retrospective-evaluation-drug-drug-interactions-erlotinib-and"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,8]]},"references-count":0,"journal-issue":{"issue":"Suppl 3","published-print":{"date-parts":[[2023,8]]}},"URL":"https:\/\/doi.org\/10.12788\/fp.0401","relation":{},"subject":[],"published":{"date-parts":[[2023,8]]}}}